Unlock the potential to accelerate GI recovery

The first and only FDA-approved agent indicated to accelerate the time to upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primaryanastomosis.

Make Entereg part of your preop and postop routine

Brand name: Entereg
Generic name/category: Alvimopan
Company: GlaxoSmithKline and Adolor
Country/Market: USA, North America
Indication(s)/use: accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis.
Target: Healthcare Professionals (HCP)
Tagline: Unlock the potential to accelerate GI recovery
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Surgery News – January 2010

To see all of this brand’s ads on AdPharm, click here

Click here for the full-sized ad and details in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.